MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
Go back to MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment| Medicinova, Inc. (NASDAQ: MNOV) | Delayed: 1.37 +0.01 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.36 | 52 Week High | $10.16 | |||
| Open | $1.36 | 52 Week Low | $2.91 | |||
| Day High | $1.37 | P/E | N/A | |||
| Day Low | $1.36 | EPS | $-0.41 | |||
| Volume | 8,002 | |||||
